Skip to main content
. 2024 May 10;15:1377705. doi: 10.3389/fpsyt.2024.1377705

Figure 2.

Figure 2

Summary results of drug-target MR. CAD, coronary artery disease; OR, odds ratio; CI, confidence interval.